Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 15;12:174–176. doi: 10.1016/j.jdin.2023.06.003

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Fig 1 — Atypical fibroxanthoma survival by treatment type. Kaplan-Meier estimate of survival to recurrence of patients with atypical fibroxanthoma treated with Mohs micrographic surgery (MMS) or wide local excision (WLE), with log-rank test P value. Not included is the Kaplan-Meier estimate of survival to death of patients with atypical fibroxanthoma treated with MMS vs WLE. Those treated with MMS had better recurrence free survival than did the WLE group (P = .024); no differences were observed in the survival to death between WLE and MMS (P = .87). The blue (WLE) and yellow (MMS) shaded regions represent the 95% confidence bands for the survival function. WLE, Wide local excision.